CRA 1001

a corticotropin-releasing factor subtype 1 receptor antagonist; structure in first source

Also Known As:

2-(N-(2-bromo-4-isopropylphenyl)-N-ethylamino)-4-(4-(3-fluorophenyl)-1,2,3,6-tetrahydropyridin-1-yl)-6-methylpyrimidine; CRA-1001; CRA1001

Networked: 0 relevant articles (0 outcomes, 0 trials/studies)